Latest News

Single dose of century-old drug approved for sleeping sickness reverses autism-like symptoms in mice

In a further test of a novel theory that suggests autism is the consequence of abnormal cell communication, researchers report that an almost century-old drug approved for treating sleeping sickness also restores normal cellular signaling in a mouse model of autism, reversing symptoms of the neurological disorder in animals that were the human biological age equivalent of 30 years old.
View full story

Post your comment.


  • Amblyopia, not strabismus, identified as key contributor to slow reading in school-age children

  • Visual stress could be a symptom of Chronic Fatigue Syndrome, research suggests

  • Lower availability of omega-3 fatty acids in the body associated with bipolar disorder

  • Rats: Sniff and track, or run and scan?

  • Two-thirds of studies on 'psychosocial' treatments fail to declare conflicts of interest

  • New protein biomarker identifies damaged brain wiring after concussion

  • Fruit flies provide new insight into body's rhythms

  • High-fat diet prompts immune cells to start eating connections between neurons

  • Want to remember new names? Sleep on it

  • Adults aged 50-59 now largest age group in opioid treatment programs